Calcific rotator-cuff tendinopathy · Review · 2025
How does shockwave rank among non-surgical options for calcific shoulder pain?
In this review of 19 trials (1160 adults), medium-energy shockwave ranked behind platelet-rich plasma, a calcium-dissolving treatment (EDTA) and needle aspiration for shoulder function. For pain, low- and medium-energy shockwave ranked level with platelet-rich plasma, behind EDTA, taping and aspiration.
Ranked mid-way among options- trials
- 19
- adults
- 1,160
- shockwave energy levels, ranked against other options
- 3
Good to know: Rankings combine direct and indirect comparisons. Shockwave settings and add-on treatments varied between trials.
Moggio L, Marotta N, de Sire A, et al. Orthopaedic Surgery, 2025 · Read the paper ↗
How this study worked
What the trials used
- ESWT intensity categories
- Authors classified high as EFD >0.3 mJ/mm², medium as >0.2 and <0.3 mJ/mm², and low as <0.2 mJ/mm². The definitions do not specify categories for exactly 0.2 or 0.3 mJ/mm². Radial and focused delivery parameters are not interchangeable.
- Study-level regimens and co-interventions
- Protocols varied substantially. Examples in Table 3 include 2,000 impulses in two sessions at EFD 0.23 versus 0.42 mJ/mm²; 2×2,000 impulses 2 weeks apart at 0.28 versus <0.07 mJ/mm²; one trial used high 0.45 versus low 0.02–0.06 mJ/mm², two sessions 2 weeks apart. Other network treatments included EDTA plus mesotherapy/ultrasound, aspiration plus PRP or corticosteroid, needle procedures, physiotherapy and exercise. These are separate multimodal study arms, not a single common comparison.
Who took part
Adults with calcium deposits in the rotator cuff confirmed on imaging, with symptoms for at least 3 months.
Side effects
The review did not pool side effects.
All the numbers and the full appraisal
What the full paper reports.
Nineteen RCTs reported 1,160 adults with imaging-confirmed rotator-cuff calcific tendinopathy; 575 were assigned to control groups. Study populations and outcome follow-up varied.
Network ranking for shoulder function (Constant–Murley Score)1 reported outcome
Network ranking for shoulder function (Constant–Murley Score)
Constant–Murley Score (CMS) SUCRA ranking probability as reported by authors; not response rate
The authors report PRP 85%, EDTA 75%, aspiration 65%, and medium-energy ESWT 57% as probabilities/rankings for best function. These are network ranking metrics, not patient improvement rates. Co-interventions are embedded: PRP was paired with aspiration, and EDTA with ultrasound.
Analysis details and source
The retrieved article provides ranking percentages in prose but no numerical network effect estimates or uncertainty intervals in a table; referenced Figure 4 pixels were not locally available for inspection.
Pain assessed using VAS or NRS across trials1 reported outcome
Network ranking for pain reduction
Pain assessed using VAS or NRS across trials SUCRA ranking probability as reported by authors; not response rate
The Results section reports EDTA 66%, kinesiotaping 62%, aspiration 61%, and low-/medium-energy ESWT and PRP 53% each. The Abstract and a later Discussion passage instead give both kinesiotaping and aspiration as 61%; this internal discrepancy is retained. Rankings do not demonstrate clinically meaningful superiority.
Analysis details and source
The article does not provide the corresponding network effect sizes/CIs in the retrieved XML text. The ranking percentages are not response proportions.
How treatment was delivered
Authors classified high as EFD >0.3 mJ/mm², medium as >0.2 and <0.3 mJ/mm², and low as <0.2 mJ/mm². The definitions do not specify categories for exactly 0.2 or 0.3 mJ/mm². Radial and focused delivery parameters are not interchangeable.
Protocols varied substantially. Examples in Table 3 include 2,000 impulses in two sessions at EFD 0.23 versus 0.42 mJ/mm²; 2×2,000 impulses 2 weeks apart at 0.28 versus <0.07 mJ/mm²; one trial used high 0.45 versus low 0.02–0.06 mJ/mm², two sessions 2 weeks apart. Other network treatments included EDTA plus mesotherapy/ultrasound, aspiration plus PRP or corticosteroid, needle procedures, physiotherapy and exercise. These are separate multimodal study arms, not a single common comparison.
The review lists adverse events among secondary outcomes but does not report a pooled adverse-event estimate or systematic event counts in the accessible main text.
The review combines different conservative interventions, co-interventions, treatment parameters, comparators and follow-up periods; its indirect comparisons depend on transitivity assumptions. Authors also note English-only inclusion and risk-of-bias concerns.
The narrative provides SUCRA rankings but no accessible numerical network effects or uncertainty intervals; the Results and Discussion also differ on kinesiotaping’s pain ranking (62% vs 61%). Figure pixels and supplementary inputs could not be checked.
Intervention nodes include treatment packages: the authors note EDTA was paired with ultrasound and PRP with aspiration, limiting attribution to isolated components.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- The review combines different conservative interventions, co-interventions, treatment parameters, comparators and follow-up periods; its indirect comparisons depend on transitivity assumptions. Authors also note English-only inclusion and risk-of-bias concerns.
- The narrative provides SUCRA rankings but no accessible numerical network effects or uncertainty intervals; the Results and Discussion also differ on kinesiotaping’s pain ranking (62% vs 61%). Figure pixels and supplementary inputs could not be checked.
- Intervention nodes include treatment packages: the authors note EDTA was paired with ultrasound and PRP with aspiration, limiting attribution to isolated components.
Source-linked critical reading
Systematic review with network meta-analysis
Technical source record
Read the full article from introduction through data availability; compared parsed extraction with all three raw table-wraps and five figure captions; reviewed intervention-specific results, NMA rankings, risk-of-bias section, discussion, limitations, conclusion and disclosures. Numerical league-table effects and figure pixels were not available in the retrieved source.
This review ranks several options for calcific shoulder tendinopathy, but its percentages describe network rankings, not the chance that a patient will improve. The accessible report does not provide enough numerical comparison detail to identify one best treatment with confidence.
Across conservative treatments for imaging-confirmed rotator-cuff calcific tendinopathy, what do the review’s network syntheses report for pain and shoulder function, and how should its treatment rankings be interpreted?
Systematic review and network meta-analysis of 19 RCTs, reporting 1,160 subjects, searched in PubMed, Scopus and Cochrane through January 2, 2024 (Methods; the Abstract says January 2, 2025); PROSPERO CRD420250650833. The report says CMS analysis included only RCTs.
Adults with imaging-confirmed calcific deposits and symptoms for at least 3 months; 1,160 subjects were reported across studies, 575 in control groups. Trials used different eligibility criteria, interventions and follow-up periods, so these totals do not describe a single cohort.
The review network spans ESWT intensity categories, ultrasound, kinesiotaping, EDTA, PRP, needling/aspiration and other conservative care. ESWT category thresholds leave boundary values unspecified; protocols vary in device energy, impulses, sessions and anesthesia. EDTA and PRP were not isolated from their associated procedures/care in the cited examples.
The network combines placebo/sham, conventional rehabilitation, alternative conservative treatments and active ESWT regimens. Some comparisons are indirect; a ranking cannot be interpreted as a randomized head-to-head effect for every pair.
Primary outcomes were pain (VAS/NRS) and function (CMS). The main XML contains narrative SUCRA percentages but no accessible numeric league table/effect estimates and confidence intervals; Figure 4 captions identify ranking plots, but the figure pixels and supplements were not available for verification.
For CMS, the authors report PRP 85%, EDTA 75%, aspiration 65% and medium-energy ESWT 57%. For pain, Results report EDTA 66%, kinesiotaping 62%, aspiration 61%, and low-/medium-energy ESWT and PRP 53% each. The Abstract and Discussion give kinesiotaping and aspiration both 61%. These percentages are rankings, not success rates; exact relative effects and uncertainty cannot be independently assessed from the retrieved text.
Adverse events were listed as a secondary outcome, but the main-text NMA section does not present pooled harm estimates or a systematic event summary. Lack of a pooled result is not evidence that treatments are harmless.
The authors acknowledge English-only inclusion, three-database searching, diverse protocols and follow-up, possible transitivity violations in indirect comparisons, and risk-of-bias concerns. Co-interventions complicate attribution. The retrieved text omits numerical network effects/intervals, and Results versus Discussion disagree on one pain-ranking percentage.
The review maps options worth discussing for calcific shoulder disease but does not establish a definitive best intervention. Its SUCRA percentages must not be converted into probabilities of an individual patient improving, especially when co-treatments and indirect comparisons are involved.
Future reviews should provide complete league tables, effect sizes with confidence intervals, certainty assessments and sensitivity analyses by intervention design. Trials should isolate treatment components, standardize ESWT reporting and measure adverse events systematically.
Read the original article.
Efficacy of Conservative Approaches on Pain Relief and Function in Patients With Rotator Cuff Calcific Tendinopathy: Which Is the Best Option? A Systematic Review and Network Meta-Analysis.
Moggio L, Marotta N, de Sire A, Benedetto GL, Gasparini G, Ammendolia A, Parrotta EI, Mercurio M. · Orthopaedic surgery · 2025
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →